Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-035394

President & CEO sold 80,000 shares at $9.12 ($729,600)

  • President & CEO acquired 80,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stonehouse Jon P · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-12-03 Exercise or conversion : show line 1 in the form +80,000 $1.20 $96,000 807,674 D
2018-12-03 Sale : show line 2 in the form −80,000 $9.12 $729,600 727,674 D
Open-market sales · 80,000 sh · avg $9.12 · $729,600

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-12-03 Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) −80,000 0 D
Loading xslF345X03/form4.xml…